Skip to main content
. 2026 Jan 11;18:125. doi: 10.1186/s13098-026-02086-3

Table 2.

Adverse events

Adverse Events FDC (n = 90) LC (n = 90) P-value Odds Ratio (95% CI)
Any AE, n (%) 8 (8.9) 1 (1.1) 0.034* 8.68 (1.07–70.4)
Serious AEs, n (%) 0 (0.0) 0 (0.0) NA NA
Discontinuations due to AE, n (%) 0 (0.0) 0 (0.0) NA NA
Deaths, n (%) 0 (0.0) 0 (0.0) NA NA
Hypoglycemia, n (%) 0 (0.0) 0 (0.0) NA NA

*p-value from Fisher’s Exact Test. † All AEs were mild and resolved without sequelae. The safety population includes all participants who received at least one dose of study medication

AE = adverse event; CI = confidence interval; FDC = fixed-dose combination; LC = loose combination; NA = not applicable